Here we assessed the effects of ADAM12 augmentation and miR-29a inhibition on perfusion recovery and capillary density in the ischemic GA muscle of HFD mice (a model of type 2 DM) following the induction of experimental PAD. The gene discussed is ADAM12; the disease is peripheral arterial disease.